Tapatybė

Chloramphenicol Impurity 18

Nenurodyta · C13H18F2N2O4S

01Tapatybė

Lazychem IDLC-45818
CAS RNNenurodyta
PubChem CID11739190
Molecular formulaC13H18F2N2O4S
Molecular weight336.36 g/mol
IUPAC name(2R)-2-amino-N-[(1R,2S)-3-fluoro-1-[4-(fluoromethylsulfonyl)phenyl]-1-hydroxypropan-2-yl]propanamide
InChIKeyNUZUAJOSZXVVNO-GGZOMVNGSA-N

02Struktūra ir stereochemija

Two-dimensional chemical structure of Chloramphenicol Impurity 18
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 1 ring, includes aromatic atoms, includes aliphatic carbon, has 3 defined stereocentres, contains at least one halogen atom. These statements are calculated from the published structure string.

Defined stereocentres3
Ring count1
Secondary amines0
Tertiary amines0
SMILESC[C@H](C(=O)N[C@H](CF)[C@@H](C1=CC=C(C=C1)S(=O)(=O)CF)O)N
InChINenurodyta

03Stereochemistry

The published structure contains 3 defined and 0 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres3Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 8Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Statusas Indijoje

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Pavadinimai ir ryšiai

API ir pirminis vaistas

Nenurodyta

Pavadinimai ir ryšiai

    06Šaltiniai